<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34076319</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-896X</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Protein science : a publication of the Protein Society</Title><ISOAbbreviation>Protein Sci</ISOAbbreviation></Journal><ArticleTitle>Free energy calculations of ALS-causing SOD1 mutants reveal common perturbations to stability and dynamics along the maturation pathway.</ArticleTitle><Pagination><StartPage>1804</StartPage><EndPage>1817</EndPage><MedlinePgn>1804-1817</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pro.4132</ELocationID><Abstract><AbstractText>With over 150 heritable mutations identified as disease-causative, superoxide dismutase 1 (SOD1) has been a main target of amyotrophic lateral sclerosis (ALS) research and therapeutic efforts. However, recent evidence has suggested that neither loss of function nor protein aggregation is responsible for promoting neurotoxicity. Furthermore, there is no clear pattern to the nature or the location of these mutations that could suggest a molecular mechanism behind SOD1-linked ALS. Here, we utilize reliable and accurate computational techniques to predict the perturbations of 10 such mutations to the free energy changes of SOD1 as it matures from apo monomer to metallated dimer. We find that the free energy perturbations caused by these mutations strongly depend on maturational progress, indicating the need for state-specific therapeutic targeting. We also find that many mutations exhibit similar patterns of perturbation to native and non-native maturation, indicating strong thermodynamic coupling between the dynamics at various sites of maturation within SOD1. These results suggest the presence of an allosteric network in SOD1 which is vulnerable to disruption by these mutations. Analysis of these perturbations may contribute to uncovering a unifying molecular mechanism which explains SOD1-linked ALS and help to guide future therapeutic efforts.</AbstractText><CopyrightInformation>&#xa9; 2021 The Protein Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wells</LastName><ForeName>Nicholas G M</ForeName><Initials>NGM</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Wesleyan University, Middletown, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tillinghast</LastName><ForeName>Grant A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Wesleyan University, Middletown, Connecticut, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Columbia University, New York, New York City, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Neil</LastName><ForeName>Alison L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-0759-4740</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Wesleyan University, Middletown, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Colin A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0002-4651-167X</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Wesleyan University, Middletown, Connecticut, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Protein Sci</MedlineTA><NlmUniqueID>9211750</NlmUniqueID><ISSNLinking>0961-8368</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001059">Apoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002413">Cations, Divalent</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance UI="D015032">Zinc</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000494" MajorTopicYN="N">Allosteric Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001059" MajorTopicYN="N">Apoproteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002413" MajorTopicYN="N">Cations, Divalent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006860" MajorTopicYN="N">Hydrogen Bonding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056004" MajorTopicYN="N">Molecular Dynamics Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072756" MajorTopicYN="N">Protein Conformation, alpha-Helical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072757" MajorTopicYN="N">Protein Conformation, beta-Strand</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054730" MajorTopicYN="N">Protein Interaction Domains and Motifs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055503" MajorTopicYN="N">Protein Multimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013816" MajorTopicYN="N">Thermodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015032" MajorTopicYN="N">Zinc</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">free energy calculations</Keyword><Keyword MajorTopicYN="N">metal binding</Keyword><Keyword MajorTopicYN="N">protein dynamics</Keyword><Keyword MajorTopicYN="N">superoxide dismutase 1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>9</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34076319</ArticleId><ArticleId IdType="pmc">PMC8376412</ArticleId><ArticleId IdType="doi">10.1002/pro.4132</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, Al&#x2010;Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott EO, Malek AM, Lacomis D. Chapter 13 &#x2010; the epidemiology of amyotrophic lateral sclerosis, editors. Handbook of Clinical Neurology. 2016:225&#x2013;238. https://www.elsevier.com/books/book-series/handbook-of-clinical-neurology
</Citation><ArticleIdList><ArticleId IdType="pubmed">27637961</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. BioMed Central. 2009;4:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Rouleau GA, Ravits J, Cashman NR. Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med. 2017;7:a024117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5538408</ArticleId><ArticleId IdType="pubmed">28003278</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon RA, Bunton&#x2010;Stasyshyn RKA, Fisher EMC, Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain. 2013;136:2342&#x2013;2358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3722346</ArticleId><ArticleId IdType="pubmed">23687121</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakavayev S, Chetrit N, Zvagelsky T, et al. Cu/Zn&#x2010;superoxide dismutase and wild&#x2010;type like fALS SOD1 mutants produce cytotoxic quantities of H(2)O(2) via cysteine&#x2010;dependent redox short&#x2010;circuit. Sci Rep. 2019;9:10826&#x2013;10826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6658568</ArticleId><ArticleId IdType="pubmed">31346243</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez JA, Valentine JS, Eggers DK, et al. Familial amyotrophic lateral sclerosis&#x2010;associated mutations decrease the thermal stability of distinctly metallated species of human copper/zinc superoxide dismutase. J Biol Chem. 2002;277:15932&#x2013;15937.</Citation><ArticleIdList><ArticleId IdType="pubmed">11854285</ArticleId></ArticleIdList></Reference><Reference><Citation>Broom HR, Rumfeldt JAO, Vassall KA, Meiering EM. Destabilization of the dimer interface is a common consequence of diverse ALS&#x2010;associated mutations in metal free SOD1. Protein Sci. 2015;24:2081&#x2013;2089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815230</ArticleId><ArticleId IdType="pubmed">26362407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindberg MJ, Tibell L, Oliveberg M. Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: Decreased stability of the apo state. Proc Natl Acad Sci. 2002;99:16607&#x2013;16612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC139191</ArticleId><ArticleId IdType="pubmed">12482932</ArticleId></ArticleIdList></Reference><Reference><Citation>Reaume AG, Elliott JL, Hoffman EK, et al. Motor neurons in Cu/Zn superoxide dismutase&#x2010;deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet. 1996;13:43&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">8673102</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratovitski T, Corson LB, Strain J, et al. Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Human Mol Genet. 1999;8:1451&#x2013;1460.</Citation><ArticleIdList><ArticleId IdType="pubmed">10400992</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasil AA, Magalh&#xe3;es RSS, De Carvalho MDC, et al. Implications of fALS mutations on Sod1 function and oligomerization in cell models. Mol Neurobiol. 2018;55:5269&#x2013;5281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5948255</ArticleId><ArticleId IdType="pubmed">28884318</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C, Beck MV, Griffith JD, Deshmukh M, Dokholyan NV. Large SOD1 aggregates, unlike trimeric SOD1, do not impact cell viability in a model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2018;115:4661&#x2013;4665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939103</ArticleId><ArticleId IdType="pubmed">29666246</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill C, Phelan JP, Hatzipetros T, et al. SOD1&#x2010;positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS. Sci Rep. 2019;9:6724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6491559</ArticleId><ArticleId IdType="pubmed">31040321</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow JP, Sampson JB, Zhuang Y, Thompson JA, Beckman JS. Decreased zinc affinity of amyotrophic lateral sclerosis&#x2010;associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J Neurochem. 1997;69:1936&#x2013;1944.</Citation><ArticleIdList><ArticleId IdType="pubmed">9349538</ArticleId></ArticleIdList></Reference><Reference><Citation>Huai J, Zhang Z. Structural properties and interaction partners of familial ALS&#x2010;associated SOD1 mutants. Front Neurol. 2019;10:527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6536575</ArticleId><ArticleId IdType="pubmed">31164862</ArticleId></ArticleIdList></Reference><Reference><Citation>Culik RM, Sekhar A, Nagesh J, et al. Effects of maturation on the conformational free&#x2010;energy landscape of SOD1. Proc Natl Acad Sci U S A. 2018;115:E2546&#x2013;e2555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856554</ArticleId><ArticleId IdType="pubmed">29483249</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchinat E, Barbieri L, Banci L. A molecular chaperone activity of CCS restores the maturation of SOD1 fALS mutants. Sci Rep. 2017;7:17433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5727297</ArticleId><ArticleId IdType="pubmed">29234142</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekhar A, Rumfeldt JAO, Broom HR, et al. Probing the free energy landscapes of ALS disease mutants of SOD1 by NMR spectroscopy. Proc Natl Acad Sci U S A. 2016;113:E6939&#x2013;e6945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5111666</ArticleId><ArticleId IdType="pubmed">27791136</ArticleId></ArticleIdList></Reference><Reference><Citation>Gapsys V, Michielssens S, Seeliger D, De Groot BL. Pmx: Automated protein structure and topology generation for alchemical perturbations. J Comput Chem. 2015;36:348&#x2013;354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4365728</ArticleId><ArticleId IdType="pubmed">25487359</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Wang J, Yin B, Pang L, Wang W, Zhu W. Molecular mechanism of binding selectivity of inhibitors toward BACE1 and BACE2 revealed by multiple short molecular dynamics simulations and free&#x2010;energy predictions. ACS Chem Nerosci. 2019;10:4303&#x2013;4318.</Citation><ArticleIdList><ArticleId IdType="pubmed">31545898</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Pang L, Wang W, Wang L, Zhang JZH, Zhu T. Decoding molecular mechanism of inhibitor bindings to CDK2 using molecular dynamics simulations and binding free energy calculations. J Biomol Struct Dynam. 2020;38:985&#x2013;996.</Citation><ArticleIdList><ArticleId IdType="pubmed">30843759</ArticleId></ArticleIdList></Reference><Reference><Citation>Gapsys V, De Groot BL. Alchemical free energy calculations for nucleotide mutations in protein&#x2013;DNA complexes. J Chem Theory Comput. 2017;13:6275&#x2013;6289.</Citation><ArticleIdList><ArticleId IdType="pubmed">29125747</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayatekin C, Zitzewitz JA, Matthews CR. Disulfide&#x2010;reduced ALS variants of Cu, Zn superoxide dismutase exhibit increased populations of unfolded fpecies. J Mol Biol. 2010;398:320&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3075925</ArticleId><ArticleId IdType="pubmed">20184893</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd SD, Ullrich MS, Calvo JS, Behnia F, Meloni G, Winkler DD. Mutations in superoxide dismutase 1 (Sod1) linked to familial amyotrophic lateral sclerosis can disrupt high&#x2010;affinity zinc&#x2010;binding promoted by the copper chaperone for Sod1 (ccs). Molecules. 2020;25:1086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179120</ArticleId><ArticleId IdType="pubmed">32121118</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Bertini I, Cantini F, D'Amelio N, Gaggelli E. Human SOD1 before harboring the catalytic metal: Solution structure of copper&#x2010;depleted, disulfide&#x2010;reduced form. J Biol Chem. 2006;281:2333&#x2013;2337.</Citation><ArticleIdList><ArticleId IdType="pubmed">16291742</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnesano F, Banci L, Bertini I, Martinelli M, Furukawa Y, O'Halloran TV. The unusually stable quaternary structure of human Cu,Zn&#x2010;superoxide dismutase 1 is controlled by both metal occupancy and disulfide status. J Biol Chem. 2004;279:47998&#x2013;48003.</Citation><ArticleIdList><ArticleId IdType="pubmed">15326189</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare SD, Caplow M, Dokholyan NV. FALS mutations in cu, Zn superoxide dismutase destabilize the dimer and increase dimer dissociation propensity: A large&#x2010;scale thermodynamic analysis. Amyloid. 2006;13:226&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">17107883</ArticleId></ArticleIdList></Reference><Reference><Citation>Das A, Plotkin SS. Mechanical probes of SOD1 predict systematic trends in metal and dimer affinity of ALS&#x2010;associated mutants. J Mol Biol. 2013;425:850&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pubmed">23291526</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirangelo I, Iannuzzi C. The role of metal binding in the amyotrophic lateral sclerosis&#x2010;related aggregation of copper&#x2010;zinc superoxide dismutase. Molecules. 2017;22:1429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6151412</ArticleId><ArticleId IdType="pubmed">28850080</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayatekin C, Zitzewitz JA, Matthews CR. Zinc binding modulates the entire folding free energy surface of human Cu,Zn superoxide dismutase. J Mol Biol. 2008;384:540&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2756654</ArticleId><ArticleId IdType="pubmed">18840448</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Bertini I, Durazo A, et al. Metal&#x2010;free superoxide dismutase forms soluble oligomers under physiological conditions: A possible general mechanism for familial ALS. Proc Natl Acad Sci U S A. 2007;104:11263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1899188</ArticleId><ArticleId IdType="pubmed">17592131</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Slunt H, Gonzales V, et al. Copper&#x2010;binding&#x2010;site&#x2010;null SOD1 causes ALS in transgenic mice: Aggregates of non&#x2010;native SOD1 delineate a common feature. Human Mol Genet. 2003;12:2753&#x2013;2764.</Citation><ArticleIdList><ArticleId IdType="pubmed">12966034</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle CM, Rumfeldt JA, Broom HR, Sekhar A, Kay LW, Meiering EM. Concurrent increases and decreases in local stability and conformational geterogeneity in cu, Zn superoxide dismutase variants revealed by temperature&#x2010;dependence of amide chemical shifts. Biochemistry. 2016;55:1346&#x2013;1361.</Citation><ArticleIdList><ArticleId IdType="pubmed">26849066</ArticleId></ArticleIdList></Reference><Reference><Citation>Das A, Plotkin SS. SOD1 exhibits allosteric frustration to facilitate metal binding affinity. Proc Natl Acad Sci U S A. 2013;110:3871&#x2013;3876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3593857</ArticleId><ArticleId IdType="pubmed">23431152</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward LJ, Rodriguez JA, Kim JW, et al. Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J Biol Chem. 2002;277:15923&#x2013;15931.</Citation><ArticleIdList><ArticleId IdType="pubmed">11854284</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd SD, Liu L, Bulla L, Winkler DD. Quantifying the interaction between copper&#x2010;zinc superoxide dismutase (Sod1) and its copper chaperone (Ccs1). J Proteomics Bioinform. 2018;11:473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6018003</ArticleId><ArticleId IdType="pubmed">29950795</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y, O'Halloran TV. Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo&#x2010; and reduced form of SOD1, leading to unfolding and oxidative aggregation. J Biol Chem. 2005;280:17266&#x2013;17274.</Citation><ArticleIdList><ArticleId IdType="pubmed">15691826</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;rnberg A, Logan DL, Marklund LS, Oliveberg M. The coupling between disulphide status, metallation and dimer interface strength in Cu/Zn superoxide dismutase. J Mol Biol. 2006;365:333&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pubmed">17070542</ArticleId></ArticleIdList></Reference><Reference><Citation>Strange RW, Antonyuk S, Hough MA, et al. The structure of holo and metal&#x2010;deficient wild&#x2010;type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis. J Mol Biol. 2003;328:877&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pubmed">12729761</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaminski GA, Friesner RA, Tirado&#x2010;Rives J, Jorgensen WL. Evaluation and reparametrization of the OPLS&#x2010;AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J Phys Chem B. 2001;105:6474&#x2013;6487.</Citation></Reference><Reference><Citation>Joung IS, Cheatham TE. Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations. J Phys Chem B. 2008;112:9020&#x2013;9041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2652252</ArticleId><ArticleId IdType="pubmed">18593145</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham MJ, Murtola T, Schulz R, et al. GROMACS: High performance molecular simulations through multi&#x2010;level parallelism from laptops to supercomputers. SoftwareX. 2015;1&#x2013;2:19&#x2013;25.</Citation></Reference><Reference><Citation>Aliev AE, Kulke M, Khaneja HS, Chudasama V, Sheppard TD, Lanigan RM. Motional timescale predictions by molecular dynamics simulations: Case study using proline and hydroxyproline sidechain dynamics. Proteins. 2014;82:195&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4282583</ArticleId><ArticleId IdType="pubmed">23818175</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindorff&#x2010;Larsen K, Piana S, Palmo K, et al. Improved side&#x2010;chain torsion potentials for the Amber ff99SB protein force field. Proteins. 2010;78:1950&#x2013;1958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2970904</ArticleId><ArticleId IdType="pubmed">20408171</ArticleId></ArticleIdList></Reference><Reference><Citation>Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. LINCS: A linear constraint solver for molecular simulations. J Comput Chem. 1997;18:1463&#x2013;1472.</Citation></Reference><Reference><Citation>Branco RJF, Fernandes PA, Ramos MJ. Molecular dynamics simulations of the enzyme Cu, Zn superoxide dismutase. J Phys Chem B. 2006;110:16754&#x2013;16762.</Citation><ArticleIdList><ArticleId IdType="pubmed">16913815</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez D, Merz KM. Molecular dynamics simulations of the mononuclear zinc&#x2010;&#x3b2;&#x2010;lactamase from Bacillus cereus . J Am Chem Soc. 2001;123:3759&#x2013;3770.</Citation><ArticleIdList><ArticleId IdType="pubmed">11457108</ArticleId></ArticleIdList></Reference><Reference><Citation>Toba S, Damodaran KV, Merz KM. Binding preferences of hydroxamate inhibitors of the matrix metalloproteinase human fibroblast collagenase. J Med Chem. 1999;42:1225&#x2013;1234.</Citation><ArticleIdList><ArticleId IdType="pubmed">10197966</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters MB, Yang Y, Wang B, F&#xfc;sti&#x2010;Moln&#xe1;r L, Weaver MN, Merz KM. Structural survey of zinc&#x2010;containing proteins and development of the zinc AMBER force fField (ZAFF). J Chem Theory Comput. 2010;6:2935&#x2013;2947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2941202</ArticleId><ArticleId IdType="pubmed">20856692</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisch MJT, Trucks GW, Schlegel HB, et al. Gaussian 03. Wallingford CT: Gaussian Inc., 2003.</Citation></Reference><Reference><Citation>Peng X, Cashman NR, Plotkin SS. Prediction of misfolding&#x2010;specific epitopes in SOD1 using collective coordinates. J Phys Chem B. 2018;122:11662&#x2013;11676.</Citation><ArticleIdList><ArticleId IdType="pubmed">30351123</ArticleId></ArticleIdList></Reference><Reference><Citation>The PyMOL Molecular Graphics System, Schr&#xf6;dinger, LLC.</Citation></Reference><Reference><Citation>Towns J, Cockerill T, Dahan M, et al. XSEDE: Accelerating scientific discovery. Comput Sci Eng. 2014;16:62&#x2013;74.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>